1. Pharmacokinetics and pharmacodynamics of orally administered ruxolitinib (INCB018424 phosphate) in renal and hepatic impairment patients. Issue 1 (19th October 2013) Authors: Chen, Xuejun; Shi, Jack G.; Emm, Thomas; Scherle, Peggy A.; McGee, Ryan F.; Lo, Yvonne; Landman, Robert R.; Punwani, Naresh G.; Williams, William V.; Yeleswaram, Swamy Journal: Clinical pharmacology in drug development Issue: Volume 3:Issue 1(2014:Jan./Feb.) Page Start: 34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The pharmacokinetics, pharmacodynamics, and safety of baricitinib, an oral JAK 1/2 inhibitor, in healthy volunteers. (December 2014) Authors: Shi, Jack G.; Chen, Xuejun; Lee, Fiona; Emm, Thomas; Scherle, Peggy A.; Lo, Yvonne; Punwani, Naresh; Williams, William V.; Yeleswaram, Swamy Journal: Journal of clinical pharmacology Issue: Volume 54:Number 12(2014:Dec.) Page Start: 1354 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗